These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36270571)

  • 21. Arachidonic acid sex-dependently affects obesity through linking gut microbiota-driven inflammation to hypothalamus-adipose-liver axis.
    Zhuang P; Shou Q; Lu Y; Wang G; Qiu J; Wang J; He L; Chen J; Jiao J; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2715-2726. PubMed ID: 28711599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice.
    Olivares M; Neyrinck AM; Pötgens SA; Beaumont M; Salazar N; Cani PD; Bindels LB; Delzenne NM
    Diabetologia; 2018 Aug; 61(8):1838-1848. PubMed ID: 29797022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gut Microbiome Modulates the Changes in Liver Metabolism and in Inflammatory Processes in the Brain of Chronic Unpredictable Mild Stress Rats.
    Lv WJ; Wu XL; Chen WQ; Li YF; Zhang GF; Chao LM; Zhou JH; Guo A; Liu C; Guo SN
    Oxid Med Cell Longev; 2019; 2019():7902874. PubMed ID: 31772709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2'-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice.
    Lee S; Goodson M; Vang W; Kalanetra K; Barile D; Raybould H
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32260563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
    Delzenne NM; Knudsen C; Beaumont M; Rodriguez J; Neyrinck AM; Bindels LB
    Proc Nutr Soc; 2019 Aug; 78(3):319-328. PubMed ID: 30628563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide-rich fractions from Enteromorpha prolifera improve hepatic steatosis and gut barrier integrity in high-fat diet-induced obese mice linking to modulation of gut microbiota.
    Zou T; Xie F; Liang P; Chen J; Wang Z; Du M; You J
    Biomed Pharmacother; 2023 Jan; 157():114034. PubMed ID: 36434956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice.
    Ke X; Walker A; Haange SB; Lagkouvardos I; Liu Y; Schmitt-Kopplin P; von Bergen M; Jehmlich N; He X; Clavel T; Cheung PCK
    Mol Metab; 2019 Apr; 22():96-109. PubMed ID: 30792016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children.
    Zhang C; Yin A; Li H; Wang R; Wu G; Shen J; Zhang M; Wang L; Hou Y; Ouyang H; Zhang Y; Zheng Y; Wang J; Lv X; Wang Y; Zhang F; Zeng B; Li W; Yan F; Zhao Y; Pang X; Zhang X; Fu H; Chen F; Zhao N; Hamaker BR; Bridgewater LC; Weinkove D; Clement K; Dore J; Holmes E; Xiao H; Zhao G; Yang S; Bork P; Nicholson JK; Wei H; Tang H; Zhang X; Zhao L
    EBioMedicine; 2015 Aug; 2(8):968-84. PubMed ID: 26425705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity and the role of the gut-liver axis in rats after oral administration of titanium dioxide nanoparticles.
    Chen Z; Zhou D; Han S; Zhou S; Jia G
    Part Fibre Toxicol; 2019 Dec; 16(1):48. PubMed ID: 31881974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eucommia bark/leaf extract improves HFD-induced lipid metabolism disorders via targeting gut microbiota to activate the Fiaf-LPL gut-liver axis and SCFAs-GPR43 gut-fat axis.
    Wang Z; Sun Y; Han Y; Chen X; Gong P; Zhai P; Yao W; Ba Q; Wang H
    Phytomedicine; 2023 Feb; 110():154652. PubMed ID: 36638713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis.
    Zhang L; Wang P; Shi M; Fang Z; Ji J; Liao X; Hu X; Chen F
    J Nutr Biochem; 2020 Jun; 80():108365. PubMed ID: 32217466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycerol-Monolaurate-Mediated Attenuation of Metabolic Syndrome is Associated with the Modulation of Gut Microbiota in High-Fat-Diet-Fed Mice.
    Zhao M; Cai H; Jiang Z; Li Y; Zhong H; Zhang H; Feng F
    Mol Nutr Food Res; 2019 Sep; 63(18):e1801417. PubMed ID: 31318165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic-induced imbalances in gut microbiota aggravates cholesterol accumulation and liver injuries in rats fed a high-cholesterol diet.
    Hu X; Wang T; Liang S; Li W; Wu X; Jin F
    Appl Microbiol Biotechnol; 2015 Nov; 99(21):9111-22. PubMed ID: 26129950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
    Mavilio M; Marchetti V; Fabrizi M; Stöhr R; Marino A; Casagrande V; Fiorentino L; Cardellini M; Kappel B; Monteleone I; Garret C; Mauriello A; Monteleone G; Farcomeni A; Burcelin R; Menghini R; Federici M
    Cell Rep; 2016 Jul; 16(3):731-43. PubMed ID: 27373162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics.
    Li D; Li Y; Yang S; Lu J; Jin X; Wu M
    Biomed Pharmacother; 2022 Sep; 153():113290. PubMed ID: 35724509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-omics approach to elucidate the gut microbiota activity: Metaproteomics and metagenomics connection.
    Guirro M; Costa A; Gual-Grau A; Mayneris-Perxachs J; Torrell H; Herrero P; Canela N; Arola L
    Electrophoresis; 2018 Jul; 39(13):1692-1701. PubMed ID: 29427518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pasture intake protects against commercial diet-induced lipopolysaccharide production facilitated by gut microbiota through activating intestinal alkaline phosphatase enzyme in meat geese.
    Ali Q; Ma S; Farooq U; Niu J; Li F; Li D; Wang Z; Sun H; Cui Y; Shi Y
    Front Immunol; 2022; 13():1041070. PubMed ID: 36569878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.